Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - KalVista Pharmaceuticals, Inc. | StockGist | StockGist

Companies
KALV
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings KALVSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

KalVista Pharmaceuticals, Inc.

Filed Jan 13, 2026

Accepted Jan 12, 2026, 7:00 PM ET

CIK 0001348911

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

KalVista Pharmaceuticals, Inc.

Person Type

PN

CUSIP: 483497103

Amendment History

2 filings

SCHEDULE 13G
Original
Jan 12, 20260000902664-26-000176
SCHEDULE 13G/A
Amendment 1
Latest
Viewing
Jan 13, 20260000902664-26-000191

Recent Filings

KalVista Pharmaceuticals, Inc.1 weeks ago

KalVista Pharmaceuticals, Inc.2 months ago

KalVista Pharmaceuticals, Inc.2 months ago

KalVista Pharmaceuticals, Inc.3 months ago

KalVista Pharmaceuticals, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice